한글목차

세계의 글리코믹스 시장은 2024년에 19억 4,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 14.59%로 성장하여 43억 9,000만 달러에 이를 것으로 예측됩니다.

글리코믹스는 생물체나 세포 내에 존재하는 유리 당쇄구조와 복합 당쇄구조를 포함한 모든 당쇄구조를 종합적으로 연구하고, 그 유전적, 생리적, 병리학적 측면을 이해하는 학문으로 정의됩니다. 만성질환 증가와 함께 고급 진단 및 치료 도구에 대한 필요성이 높아지면서 세계 글리코믹스 시장의 성장을 크게 견인하고 있습니다.

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 글리코믹스 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(효소, 키트, 시약, 기기)
  • 용도별(Drug Discovery & Development, 진단, 기타)
  • 최종사용자별(학술기관 및 연구기관, 제약 기업 및 바이오테크놀러지 기업, 바이오의약품 기업, CRO)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 글리코믹스 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 글리코믹스 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 글리코믹스 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 글리코믹스 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 남아프리카공화국

제10장 남미의 글리코믹스 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병(M&A)
• 제품 출시
• 최근 동향

제13장 세계의 글리코믹스 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제15장 경쟁 구도

• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Agilent Technologies Inc.
• Bruker Corporation
• New England Biolabs Inc.
• Shimadzu Corporation
• Waters Corporation
• Takara Bio USA Inc
• Asparia Glycomics
• RayBiotech Life, Inc.

제16장 전략적 제안

제17장 회사 소개 및 면책조항

영문목차

The Global Glycomics Market, valued at USD 1.94 Billion in 2024, is projected to experience a CAGR of 14.59% to reach USD 4.39 Billion by 2030. Glycomics is defined as the comprehensive study of glycomes, encompassing all glycan structures, whether free or complex molecules, within an organism or cell, to understand their genetic, physiological, and pathological aspects. The global glycomics market growth is significantly driven by the increasing prevalence of chronic diseases, necessitating advanced diagnostic and therapeutic tools.

Key Market Drivers

The escalating global burden of chronic and infectious diseases significantly propels the glycomics market, as glycans are integral to disease pathology, immune modulation, and pathogen interactions, necessitating advanced diagnostic and therapeutic tools. Conditions such as cancer, autoimmune disorders, and metabolic diseases, including diabetes, demand sophisticated glycomics-based solutions for early detection and targeted interventions. According to the International Diabetes Federation, in 2023, an estimated 537 million adults aged 20-79 years were living with diabetes worldwide, underscoring the substantial patient population requiring improved approaches to disease management. This pervasive disease prevalence directly stimulates demand for glycomics research and applications, fostering the discovery of novel glycan biomarkers and the development of targeted glycan-based drugs and vaccines to address critical unmet medical needs.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent structural complexity and vast diversity of glycan structures. This biological intricacy profoundly complicates comprehensive analysis and standardization efforts essential for advancing glycomics applications. The extensive range of glycan configurations and their context-dependent roles necessitate highly specialized and often costly analytical techniques, leading to prolonged research and development cycles.

Key Market Trends

The integration of artificial intelligence and machine learning in glycan data analysis represents a transformative trend, enabling researchers to process and interpret the vast, complex datasets generated from glycomics studies with greater efficiency and accuracy. These technologies are crucial for identifying patterns and correlations in glycan structures that were previously challenging to detect. For example, according to GlycanML: A Multi-Task and Multi-Structure Benchmark for Glycan Machine Learning, published on arXiv in May 2024, machine learning models are being developed to predict glycan taxonomy, immunogenicity, glycosylation types, and protein-glycan interactions across diverse tasks. This analytical capability accelerates biomarker discovery and therapeutic development by translating complex glycomics information into actionable insights.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Merck KgaA
• Agilent Technologies Inc.
• Bruker Corporation
• New England Biolabs Inc.
• Shimadzu Corporation
• Waters Corporation
• Takara Bio USA Inc
• Asparia Glycomics
• RayBiotech Life, Inc.

Report Scope:

In this report, the Global Glycomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Glycomics Market, By Product:

• Enzymes
• Kits
• Reagents
• Instruments

Glycomics Market, By Application:

• Drug Discovery & Development
• Diagnostics
• Others

Glycomics Market, By End Use:

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Biopharmaceutical Companies
• CROs

Glycomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Glycomics Market.

Available Customizations:

Global Glycomics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Glycomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Enzymes, Kits, Reagents, Instruments)
  • 5.2.2. By Application (Drug Discovery & Development, Diagnostics, Others)
  • 5.2.3. By End Use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Biopharmaceutical Companies, CROs)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Glycomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Glycomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Glycomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Glycomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Glycomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Glycomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Glycomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Glycomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Glycomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Glycomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Glycomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Glycomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Glycomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Glycomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Glycomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Glycomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Glycomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Glycomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Glycomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Glycomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Glycomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Glycomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Glycomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Glycomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Glycomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck KgaA
• 15.3. Agilent Technologies Inc.
• 15.4. Bruker Corporation
• 15.5. New England Biolabs Inc.
• 15.6. Shimadzu Corporation
• 15.7. Waters Corporation
• 15.8. Takara Bio USA Inc
• 15.9. Asparia Glycomics
• 15.10. RayBiotech Life, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer